Abstract:As a proinflammatory cytokine, tumor necrosis factor-like weak inducer of apoptosis (TWEAK) participates in the progression of renal fibrosis by binding to its receptor, fibroblast growth factor-inducible 14 (Fn14). However, the effect of Fn14 inhibition on tubular epithelial cell-mediated tubulointerstitial fibrosis remains unclear. This study aimed to elucidate the role of TWEAK/Fn14 interaction in the development of experimental tubulointerstitial fibrosis as well as the protective effect of Fn14 knockdown on proximal tubular epithelial cells.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of suppressing fibroblast growth factor - inducible protein 14 (Fn14) in experimental tubulointerstitial fibrosis, especially its impact on the fibrosis process mediated by proximal tubular epithelial cells (PTECs). Specifically, the study aims to clarify the role of the interaction between tumor necrosis factor - like weak inducer of apoptosis (TWEAK) and Fn14 in the development of experimental tubulointerstitial fibrosis and evaluate the protective effect of Fn14 knockdown on proximal tubular epithelial cells. ### Research Background and Objectives TWEAK is involved in the progression of renal fibrosis by binding to its receptor Fn14. However, the effect of Fn14 inhibition on tubulointerstitial fibrosis mediated by renal tubular epithelial cells remains unclear. Therefore, the main objectives of this study are: 1. **Clarify the role of the TWEAK/Fn14 signaling pathway in tubulointerstitial fibrosis**: By constructing a unilateral ureteral obstruction (UUO) mouse model, observe the tubulointerstitial pathological changes in wild - type and Fn14 - deficient mice. 2. **Evaluate the protective effect of Fn14 knockdown on proximal tubular epithelial cells**: Verify the effect of TWEAK on the expression of fibrosis markers in PTECs through in vitro experiments and explore the role of the Notch1/Jagged1 signaling pathway in this process. ### Main Findings - **Fn14 deficiency alleviates tubulointerstitial fibrosis in the UUO mouse model**: Including reducing inflammatory cell infiltration, cell proliferation, and decreasing the deposition of pro - fibrotic factors and extracellular matrix. - **TWEAK enhances the expression of fibrosis markers in PTECs**: TWEAK increases the expression of collagen I, fibronectin, and α - smooth muscle actin (α - SMA) in a dose - dependent manner. - **Activation of the Notch1/Jagged1 signaling pathway is involved in the TWEAK - induced fibrosis process**: Inhibiting the Notch1/Jagged1 signaling pathway can relieve the effect of TWEAK on PTECs. ### Conclusions The TWEAK/Fn14 signaling pathway promotes tubulointerstitial fibrosis by acting on proximal tubular epithelial cells. Inhibition of Fn14 may be a potential therapeutic strategy for preventing renal interstitial fibrosis. This finding provides new insights into understanding the role of TWEAK/Fn14 in renal fibrosis and a theoretical basis for developing new treatment methods.

Inhibition of fibroblast growth factor-inducible 14 attenuates experimental tubulointerstitial fibrosis and profibrotic factor expression of proximal tubular epithelial cells

Upregulation of Mirna-1228-3p Alleviates TGF-β-induced Fibrosis in Renal Tubular Epithelial Cells.

Interleukin-22 attenuates renal tubular cells inflammation and fibrosis induced by TGF-β1 through Notch1 signaling pathway

Kidney tubular epithelial cells control interstitial fibroblast fate by releasing TNFAIP8-encapsulated exosomes

Mice Overexpressing Latent Tgf-Beta 1 Are Protected Against Renal Fibrosis In Obstructive Kidney Disease

Out of the TWEAKlight: Elucidating the Role of Fn14 and TWEAK in Acute Kidney Injury

Smad7 Inhibits Fibrotic Effect of TGF- on Renal Tubular Epithelial Cells by Blocking Smad2 Activation

Pharmacological Inhibition of STING/TBK1 Signaling Attenuates Myeloid Fibroblast Activation and Macrophage to Myofibroblast Transition in Renal Fibrosis

Fn14, a Downstream Target of the TGF-β Signaling Pathway, Regulates Fibroblast Activation

Forsythiaside A suppresses renal fibrosis and partial epithelial-mesenchymal transition by targeting THBS1 through the PI3K/AKT signaling pathway

MiR-92a-3p Knockdown Attenuates Transforming Growth Factor-β1-induced Tubulointerstitial Fibrosis by Targeting LIN28A-mediated EMT Pathway

Tubular cell transcriptional intermediary factor 1γ deficiency exacerbates kidney injury-induced tubular cell polyploidy and fibrosis

WNT1‐inducible signaling protein‐1 mediates TGF‐β1‐induced renal fibrosis in tubular epithelial cells and unilateral ureteral obstruction mouse models via autophagy

Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis

Targeted inhibition of TGF-β type I receptor by AZ12601011 protects against kidney fibrosis

Sp1-like protein KLF13 acts as a negative feedback regulator of TGF-(3 signaling and fibrosis

Blockade of TMEM16A protects against renal fibrosis by reducing intracellular Cl − concentration

Sp1-like protein KLF13 acts as a negative feedback regulator of TGF-β signaling and fibrosis

TWEAK/Fn14 and Non-Canonical NF-kappaB Signaling in Kidney Disease

Modulation of transforming growth factor-β-induced kidney fibrosis by leucine-rich ⍺-2 glycoprotein-1

Inhibition of TRPC6 suppressed TGFβ-induced fibroblast-myofibroblast transdifferentiation in renal interstitial NRK-49F cells